The global medical tubing market was valued at USD 12.6 billion in 2025. The market is projected to grow from USD 13.55 billion in 2026 to USD 24 billion by 2034, exhibiting a compound annual growth rate of 7.41% during the forecast period. Contrive Datum Insights presents this information in its report titled "Medical Tubing Market Size, Share & Industry Analysis, By Type (PVC, Polyolefin, TPE & TPU, Silicone, Other), Application (Bulk Disposable Tubing, Catheters & Cannulas, Drug Delivery Systems, Other), End user (Hospitals & Clinics, Ambulatory Surgical Centers, Home Healthcare Settings, Diagnostic & Research Laboratories), Manufacturing process (Extrusion, Co-Extrusion & Multi-Lumen, Braided/Reinforced Tubing), Sterilization method (Ethylene Oxide (EtO), Gamma Irradiation, E-Beam Sterilization), and Regional Forecast, 2026-2034".
Medical tubing is a category of polymer and elastomer components manufactured to precise dimensional and biocompatibility standards for use in fluid transfer, drug delivery, and diagnostic devices. It takes the form of extruded single-lumen and multi-lumen tubing, catheters, cannulas, and custom-molded assemblies supplied in materials ranging from PVC and polyolefins to silicone and thermoplastic elastomers. Buyers are principally medical device manufacturers, contract manufacturers, and hospital supply networks that integrate these components into finished devices such as IV sets, catheters, feeding tubes, and drug delivery systems.
Rising chronic disease burden and procedure volumes
Rising chronic disease burden and procedure volumes is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 7.41% a year, the type lines exposed to it move fastest: Silicone compounds at 9.85%, taking its share of revenue from 18% to 22% and its value from USD 2.27 billion to USD 5.28 billion.
A more favourable outcome is possible. If the bull case assumes faster conversion of biologics pipelines into commercial drug-delivery tubing demand and quicker expansion of home infusion programs across North America and Europe, 2034 revenue reaches USD 27 billion instead of the USD 24 billion the base case carries.
Against that, the bear case assumes tighter capital spending by device manufacturers delays new procedure volume growth and regulatory reformulation costs slow the shift away from PVC longer than expected. On that reading 2034 revenue stops at USD 21 billion. The weight of the problem sits in PVC: 34% of 2025 revenue growing at 5.11%, well under the market's 7.41%.
PVC Scale Against Silicone Momentum
Competition in the global medical tubing market runs along the type axis, not the regional one. PVC holds 34% of 2025 revenue at USD 4.28 billion and remains the largest line through 2034 at 28%, making it the position hardest for a challenger to take. Silicone, growing at 9.85%, is where share actually changes hands. A supplier established in one is not thereby established in the other, so a field of this size persists in a market of USD 12.6 billion.
Further Report Findings
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Application | Bulk Disposable Tubing | 38% · USD 4.79 billion | Drug Delivery Systems 9.99% |
| End user | Hospitals & Clinics | 52% · USD 6.55 billion | Home Healthcare Settings 9.99% |
| Manufacturing process | Extrusion | 58% · USD 7.31 billion | Braided/Reinforced Tubing 9.05% |
| Sterilization method | Ethylene Oxide (EtO) | 55% · USD 6.93 billion | E-Beam Sterilization 10.91% |
- North America was the largest region in 2025, holding 36% of global revenue at USD 4.54 billion and reaching USD 7.68 billion by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 24% in 2025 to 30% in 2034, with revenue growing from USD 3.02 billion to USD 7.2 billion.
- At 5% of 2025 revenue and 5.5% by 2034, Middle East and Africa is the smallest region throughout.
- PVC was the leading type line in 2025, taking 34% of revenue at USD 4.28 billion.
- Silicone is projected to grow at 9.85% over the forecast period, the fastest of any type line.
- The United States is the largest single country market at USD 3.54 billion in 2025, 28.1% of global revenue.
The study covers five axes, by type, and by application, end user, manufacturing process and sterilization method, reporting revenue and a growth rate for every line in every year from 2020 to 2034, with bear, base and bull scenarios on the headline total at USD 21 billion and USD 27 billion by 2034. Country-level detail is given for all five regions, together with the competitive landscape and the research methodology. Delivered as a PDF; request a free sample to review it.